Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats

Qing Li1, Zhenzhen Qu1, Zhuofeng Mao1

  • 1Department of Neurology, Key Laboratory of Neurology of Hebei Province, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.

PubMed
Abstract

Insights

Dihydromyricetin (DHM) reduces seizures and cognitive decline in epilepsy by inhibiting NLRP3 inflammasome-driven inflammation and pyroptosis, offering neuroprotection.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The NLRP3 inflammasome pathway is implicated in neurological disorders like epilepsy.
  • Dihydromyricetin (DHM) demonstrates neuroprotective properties, but its role in epilepsy-related cognitive impairment via NLRP3 is unclear.

Purpose of the Study:

  • To investigate DHM's effect on the NLRP3 inflammasome pathway in a rat model of epilepsy.
  • To determine if DHM can mitigate neuronal injury and cognitive deficits associated with pilocarpine-induced seizures.

Main Methods:

  • Established a pilocarpine-induced epilepsy model in rats.
  • Assessed seizure frequency/duration, neuronal damage (Nissl staining), and cognitive function (Morris water maze).
  • Analyzed NLRP3 inflammasome components, pyroptosis markers, and synaptic protein expression in the hippocampus.

Main Results:

  • DHM treatment reduced seizure frequency and duration post-status epilepticus (SE).
  • DHM improved cognitive function and long-term potentiation, increasing synaptic protein expression.
  • DHM protected hippocampal pyramidal neurons, potentially by inhibiting NLRP3-associated pyroptosis.

Conclusions:

  • DHM demonstrates therapeutic potential for epilepsy and associated cognitive impairment.
  • Inhibition of pyroptosis and inflammation by DHM underlies its neuroprotective effects in epilepsy.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
249
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
166
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85